Brief: Zevra Announces Closing Of Sale Of Rare Pediatric Disease Priority Review Voucher
07/04/2025 13:40
April 7 (Reuters) - Zevra Therapeutics Inc ZVRA.O: ZEVRA ANNOUNCES CLOSING OF SALE OF RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER FOR $150 MILLION Source text: ID:nGNX97rQJ1 Further company coverage: ZVRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zevra Therapeutics
See all newsZevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Zevra Therapeutics Q2 revenue rises 53% on MIPLYFFA sales
Zevra Therapeutics Inc expected to post earnings of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor